Cargando…

Treg increases HepG2 cell growth by RANK-RANKL pathway

Detalles Bibliográficos
Autores principales:	Ye, Yunbin, Zhou, Zhifeng, Gu, Weiwei, Peng, Feng, Li, Jieyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292525/ http://dx.doi.org/10.1186/2051-1426-2-S3-P240

Ejemplares similares

Evaluation of the effect of Nigella sativa extract on human hepatocellular adenocarcinoma cell line (HepG2) in vitro
por: Khan, Fazal, et al.
Publicado: (2014)

Chromatin remodeling induced by histone deacetylase inhibitors (HDACis) in HeLa, NIH 3T3 and HepG2 cells
por: Felisbino, Marina B, et al.
Publicado: (2013)

Effects of hyperglycemia on the regulation and expression of the Apoe, Igfbp1 and Foxo1 genes and on nuclear phenotypes in HepG2 cells
por: Ghiraldini, Flávia G, et al.
Publicado: (2013)

RANK and RANKL expression in RA synovium and lymph nodes as markers of dendritic cell-T cell interactions
por: Page, G, et al.
Publicado: (2004)

TiO2 nanoparticles induced micronucleus formation in human liver (HepG2) cells: comparison of conventional and flow cytometry based methods
por: Vallabani, NV Srikanth, et al.
Publicado: (2014)

Anti-tumor effect of volatile oil from Houttuynia cordata Thunb. on HepG2 cells and HepG2 tumor-bearing mice
por: Yang, Linsong, et al.
Publicado: (2019)

TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells
por: Kinsella, Gemma K., et al.
Publicado: (2021)

Artificial cells eavesdropping on HepG2 cells
por: Westensee, Isabella Nymann, et al.
Publicado: (2023)

Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway
por: TAGHIYEV, ASAF, et al.
Publicado: (2012)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
por: Tanaka-yachi, Rieko, et al.
Publicado: (2022)

VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014)

Characterization of dengue virus entry into HepG2 cells
por: Suksanpaisan, Lukkana, et al.
Publicado: (2009)

Selectivity of biopolymer membranes using HepG2 cells
por: Lü, Dongyuan, et al.
Publicado: (2015)

Curcumin Effect on Copper Transport in HepG2 Cells
por: Berzina, Anita, et al.
Publicado: (2018)

Cholesterol-lowing effect of taurine in HepG2 cell
por: Guo, Junxia, et al.
Publicado: (2017)

Nevirapine induced mitochondrial dysfunction in HepG2 cells
por: Paemanee, Atchara, et al.
Publicado: (2017)

The Expectation and Reality of the HepG2 Core Metabolic Profile
por: Kiseleva, Olga I., et al.
Publicado: (2023)

Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells.
por: Kawakami-Kimura, N., et al.
Publicado: (1997)

Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis
por: Kuang, Ye, et al.
Publicado: (2018)

The crucial role of osteocyte-derived RANKL in bone homeostasis
por: Nakashima, Tomoki, et al.
Publicado: (2012)

The monoacylglycerol acyltransferase pathway contributes to triacylglycerol synthesis in HepG2 cells
por: McFie, Pamela J., et al.
Publicado: (2022)

Cereulide and Deoxynivalenol Increase LC3 Protein Levels in HepG2 Liver Cells
por: Beisl, Julia, et al.
Publicado: (2022)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

Alterations in cellular and organellar phospholipid compositions of HepG2 cells during cell growth
por: Tsuji, Tokuji, et al.
Publicado: (2021)

HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019)

Neutrophils are the source of IL-17 and RANKL in zymosan induced arthritis
por: Milanova, Viktoriya I, et al.
Publicado: (2012)

Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway
por: Lv, Tao, et al.
Publicado: (2018)

Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells
por: Okumura, Manabu, et al.
Publicado: (2022)

RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages
por: Mota, Ryerson Fonseca, et al.
Publicado: (2022)

Lipid synthesis and secretion in HepG2 cells is not affected by ACTH
por: Skoog, Maria, et al.
Publicado: (2010)

Cadmium Impairs p53 Activity in HepG2 Cells
por: Urani, C., et al.
Publicado: (2014)

RNA-Sequencing Analysis of HepG2 Cells Treated with Atorvastatin
por: Stormo, Camilla, et al.
Publicado: (2014)

Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells
por: Wang, Qing-Qing, et al.
Publicado: (2011)

NOX1 Supports the Metabolic Remodeling of HepG2 Cells
por: Bertram, Katharina, et al.
Publicado: (2015)

Glucose availability determines silver nanoparticles toxicity in HepG2
por: Zuberek, Mariusz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fk98k28m1jfipj6p4cqmo3b1c1